Skip to main content

Modulation of Xenogeneic T-cell Proliferation by B7 and mTOR Blockade of T Cells and Porcine Endothelial Cells.

Publication ,  Journal Article
Li, S; Xu, H; Kirk, AD
Published in: Transplantation
May 1, 2022

BACKGROUND: Activation of porcine endothelial cells (PECs) is the mechanistic centerpiece of xenograft rejection. This study sought to characterize the immuno-phenotype of human T cells in response to PECs and to explore the immuno-modulation of B7 and mammalian target of rapamycin blockade of T cells and/or PECs during xeno-responses. METHODS: Rapid memory T-cell (TM) responses to PECs were assessed by an intracellular cytokine staining. T-cell proliferation to PEC with or without belatacept or rapamycin was evaluated by a mixed lymphocyte-endothelial cell reaction (MLER). Additionally, rapamycin-pretreated PECs were used in MLER. Cell phenotypes were analyzed by flow cytometry. RESULTS: Tumor necrosis factor-α/interferon-γ producers were detected in CD8+ cells stimulated by human endothelium but not PECs. MLER showed proliferation of CD4+ and CD8+ cells with predominantly memory subsets. Purified memory and naive cells proliferated following PEC stimulation with an increased frequency of TM in PEC-stimulated naive cells. Proliferating cells upregulated programmed cell death-1 (PD-1) and CD2 expression. Belatacept partially inhibited T-cell proliferation with reduced CD2 expression and frequency of the CD8+CD2highCD28- subset. Rapamycin dramatically inhibited PEC-induced T-cell proliferation, and rapamycin-preconditioned PECs failed to induce T-cell proliferation. PD-1 blockade did not restore T-cell proliferation to rapamycin-preconditioned PECs. CONCLUSIONS: Humans lack rapid TM-mediated responses to PECs but induce T-cell proliferative responses characterized largely as TM with increasing CD2 and PD-1 expression. B7-CD28 and mammalian target of rapamycin blockade of T cells exhibit dramatic inhibitory effects in altering xeno-proliferating cells. Rapamycin alters PEC xeno-immunogenicity leading to inhibition of xeno-specific T-cell proliferation independent of PD-1-PD ligand interaction.

Duke Scholars

Published In

Transplantation

DOI

EISSN

1534-6080

Publication Date

May 1, 2022

Volume

106

Issue

5

Start / End Page

950 / 962

Location

United States

Related Subject Headings

  • TOR Serine-Threonine Kinases
  • Swine
  • Surgery
  • Sirolimus
  • Programmed Cell Death 1 Receptor
  • Mammals
  • Humans
  • Endothelial Cells
  • Cell Proliferation
  • B7 Antigens
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Li, S., Xu, H., & Kirk, A. D. (2022). Modulation of Xenogeneic T-cell Proliferation by B7 and mTOR Blockade of T Cells and Porcine Endothelial Cells. Transplantation, 106(5), 950–962. https://doi.org/10.1097/TP.0000000000003920
Li, Shu, He Xu, and Allan D. Kirk. “Modulation of Xenogeneic T-cell Proliferation by B7 and mTOR Blockade of T Cells and Porcine Endothelial Cells.Transplantation 106, no. 5 (May 1, 2022): 950–62. https://doi.org/10.1097/TP.0000000000003920.
Li, Shu, et al. “Modulation of Xenogeneic T-cell Proliferation by B7 and mTOR Blockade of T Cells and Porcine Endothelial Cells.Transplantation, vol. 106, no. 5, May 2022, pp. 950–62. Pubmed, doi:10.1097/TP.0000000000003920.

Published In

Transplantation

DOI

EISSN

1534-6080

Publication Date

May 1, 2022

Volume

106

Issue

5

Start / End Page

950 / 962

Location

United States

Related Subject Headings

  • TOR Serine-Threonine Kinases
  • Swine
  • Surgery
  • Sirolimus
  • Programmed Cell Death 1 Receptor
  • Mammals
  • Humans
  • Endothelial Cells
  • Cell Proliferation
  • B7 Antigens